Corvus Pharmaceuticals, Inc. Other Non-Current Liabilities
Corvus Pharmaceuticals, Inc. (CRVS) had Other Non-Current Liabilities of $869.00 thousand as of 2018-12-31, per its 10-K filed 2020-03-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2020-03-09
- 2018-12-31: Other Liabilities, Noncurrent $869.00K.
- 2018-09-30: Other Liabilities, Noncurrent $627.00K.
- 2018-06-30: Other Liabilities, Noncurrent $741.00K.
- 2018-03-31: Other Liabilities, Noncurrent $857.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2018-12-31 | $869.00K 10-K · filed 2020-03-09 |
| 2018-09-30 | $627.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $741.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $857.00K 10-Q · filed 2018-05-03 |
| 2017-12-31 | $971.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | $1.08M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $1.19M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $1.30M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $1.41M 10-K · filed 2018-03-01 |
| 2016-09-30 | $1.26M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $1.35M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $1.29M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $710.00K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |